Management of infantile hemangiomas in the otorhinolaryngological (ENT) region

Infantile hemangiomas (IHs) are the most prevalent benign vascular tumors in pediatric populations, with an incidence of approximately 5 to 10% in infants under one year of age. IHs in the otorhinolaryngological (ENT) region present significant diagnostic and therapeutic challenges due to their potential impact on critical functions such as respiration and phonation. This study provides a comprehensive analysis of the epidemiological and clinical characteristics, therapeutic modalities, and outcomes of IHs in the ENT region. Despite therapeutic advancements, the complex nature of IHs in the ENT region necessitates a multidisciplinary approach for optimal management. This study highlights the imperative of early diagnosis and individualized therapeutic strategies to mitigate complications and enhance patient outcomes.